Rekvina Laboratories Limited Stock

Stocks

526075

INE092O01028

Market Closed - Bombay S.E. 06:02:29 2026-09-22 EDT			5-day change	1st Jan Change
53.00 ^INR	-1.56%		-9.17%	+1,077.78%

09-12	Rekvina Laboratories Limited Announces Resignation of Amit Mukesh Shah from Director, Effective September 11, 2026	CI
09-12	Rekvina Laboratories Limited Announces Resignation of Amit Mukesh Shah from Managing Director, Effective September 11, 2026	CI

Valuation: Rekvina Laboratories Limited

Market Cap	589M 6.16M 5.39M 5.06M 4.62M 8.67M 8.67M 60.75M 23.44M 301M 23.14M 22.64M 970M	P/E 2025	-19.6x	P/E 2026	-85.6x
Enterprise Value	604M 6.32M 5.52M 5.19M 4.73M 8.88M 8.89M 62.25M 24.02M 308M 23.72M 23.2M 994M	EV / Sales 2025	-	EV / Sales 2026	18,372,546x
Free-Float	-	Yield 2025 *	-	Yield 2026	-

* Estimated data More valuation ratios

Chart: Rekvina Laboratories Limited

Dynamic Chart

Latest news: Rekvina Laboratories Limited

09-12	Rekvina Laboratories Limited Announces Resignation of Amit Mukesh Shah from Director, Effective September 11, 2026	CI
09-12	Rekvina Laboratories Limited Announces Resignation of Amit Mukesh Shah from Managing Director, Effective September 11, 2026	CI
09-02	Rekvina Laboratories Limited Announces Resignation of Deepak Khandelwal as Company Secretary & Compliance Officer, Effective September 2, 2026	CI
08-13	Rekvina Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
08-13	Rekvina Laboratories Limited Announces Appointment of Surbhit Shah as Chairman of the Board	CI
07-13	Surbhit Mukesh Shah, the managing director of Rekvina Laboratories Limited, Amit Mukesh Shah, the director of Rekvina Laboratories Limited and Dhruvalkumar Patel completed the acquisition of an additional 23.22% stake in Rekvina Laboratories Limited for INR 14.41 million.	CI
05-21	Rekvina Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
03-15	Rekvina Laboratories Limited entered into agreement to acquire Radiant Parenterals Limited from Surbhit Mukesh Shah, Amit Mukesh Shah, Dhruvalkumar Patel, Krima Surbhit Shah and Ami Amit Shah for approximately INR 140 million.	CI
03-15	Surbhit Mukesh Shah and Amit Mukesh Shah, the directors of Rekvina Laboratories Limited and Dhruvalkumar Patel proposed to acquire an additional 47.94% stake in Rekvina Laboratories Limited for INR 28.9 million.	CI
03-10	Rekvina Laboratories Limited announced that it expects to receive INR 4.6 million in funding	CI
02-06	Rekvina Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
01-29	Rekvina Laboratories Limited Announces the Resignation of Chetanbhai Jayantibhai Patel as Non- Executive Independent Director and from Membership in Various Committees, Effective from 29 January 2026	CI
01-09	Rekvina Laboratories Limited Announces Resignation of Dhruvalkumar Jayantilal Patel as Non-Executive Independent Director, Effective January 9, 2026	CI

More news

Quotes and Performance

1 day	-1.56%
1 week	-9.17%
Current month	+6.53%
1 month	+27.04%
3 months	+41.52%
6 months	+61.34%
Current year	+1,077.78%

More quotes

Price Extremes

1 week	52.77	56.05
1 month	41	59.4
Current year	6.75	59.4
1 year	6.75	59.4
3 years	6.75	59.4
5 years	4.18	59.4
10 years	3.6	59.4

More quotes

Managers and Directors: Rekvina Laboratories Limited

Manager	Title	Age	Since
Surbhit Shah DFI	Director of Finance/CFO	43	2024-09-01

Director	Title	Age	Since
Nilesh Harkesh Yadav BRD	Director/Board Member	24	2024-05-21
Surbhit Shah BRD	Director/Board Member	43	2024-09-01
Ilaben Pathak CHM	Chairman	31	2024-10-04

More insiders

Financials

	2025	2026
Net sales	-	12.65 0.13 0.12 0.11 0.1 0.19 0.19 1.3 0.5 6.46 0.5 0.49 20.83
Net income	-1.37M -14.34K -12.53K -11.78K -10.75K -20.17K -20.18K -141K -54.55K -700K -53.86K -52.68K -2.26M	-2.55M -26.64K -23.28K -21.88K -19.97K -37.48K -37.49K -263K -101K -1.3M -100K -97.86K -4.19M
Net Debt	2.22M 23.2K 20.28K 19.06K 17.39K 32.64K 32.64K 229K 88.25K 1.13M 87.13K 85.22K 3.65M	14.57M 152K 133K 125K 114K 214K 214K 1.5M 580K 7.44M 573K 560K 23.99M